Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis

Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB)

(2012) Gregory Pancari et al.   Frontiers in Cellular and Infection Microbiology

Progress Toward a Staphylococcus aureus Vaccine

(2011) R. S. Daum et al.   CLINICAL INFECTIOUS DISEASES

Is there a future for a Staphylococcus aureus vaccine?

(2011) Richard A. Proctor   VACCINE

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

(2011) Clayton D. Harro et al.   VACCINE

Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans

(2010) C. Harro et al.   Clinical and Vaccine Immunology

Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients

(2009) Y. Li et al.   Clinical Journal of the American Society of Nephrology

Impaired Immune Responses and Antigen-Specific Memory CD4+ T Cells in Hemodialysis Patients

(2008) N. H. R. Litjens et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY